Thomas Kryza

9PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer cell biologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 27, 2025
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers.

Madeline Gough, Kayden K X Kwah, Tashbib Khan

|Jun 27, 2023
Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer.

Madeline Gough, Cheng Liu, Bhuvana Srinivasan

|Feb 01, 2022
Remodelling of the tumour microenvironment by the kallikrein-related peptidases.

Srilakshmi Srinivasan, Thomas Kryza, Jyotsna Batra

|Jul 01, 2021
In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer.

Nathalie Bock, Thomas Kryza, Ali Shokoohmand

|Apr 16, 2021
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1.

Thomas Kryza, Tashbib Khan, Scott Lovell

|Jan 29, 2021
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention.

Tashbib Khan, Thomas Kryza, Nicholas J Lyons

Pageof 2

Frequent Collaborators

4 joint publications

John D Hooper

2 joint publications

Brian W-C Tse

2 joint publications

Tashbib Khan

2 joint publications

Cameron E Snell